Answers are grounded in this paper and cite their sources.
Background Intense exercise may transiently alter iron metabolism through inflammatory and oxidative mechanisms. Anthocyanin-rich black chokeberry (Aronia melanocarpa) may influence these responses and short-term iron regulation. This study evaluated the effects of black chokeberry supplementation on iron metabolism, inflammation, antioxidant capacity, and hematological status in female competitive swimmers.Methods Twenty-two female swimmers (13.14 ± 1.42 years) were randomly allocated to a supplementation or placebo group. Participants completed two identical swimming tests comprising 800-, 200-, and 50-m efforts before and after 57.32 ± 8.31 days of supplementation. Blood was collected before exercise, immediately after exercise, and after 3 h of recovery.Results Most inflammatory markers showed time-dependent changes without significant group effects. C-reactive protein decreased from pre- to post-exercise during the second test in the supplemented group (p = 0.0325; Cohen’s d = 1.29), whereas placebo recovery values increased between tests (p < 0.0001; Cohen’s d = 3.33). Total antioxidant capacity showed a significant time × group interaction (p = 0.0007), with higher recovery values in the supplemented group. Iron, unsaturated iron-binding capacity, and total iron-binding capacity showed significant time effects (all p < 0.0001). Hepcidin also showed a significant time effect, with significant within-group increases only in the placebo group. Transferrin was lower in the supplemented group at Post II (p = 0.0071; Cohen’s d = 1.17), whereas ferritin remained unchanged and hematological parameters showed no consistent between-group differences.Conclusion Black chokeberry supplementation may influence markers related to short-term post-exercise iron availability, potentially in association with inflammatory and antioxidant responses, without detectable effects on body iron stores or erythropoiesis.Clinical trial registration The study was retrospectively registered at ClinicalTrials.gov (identifier: NCT06486623; registration date: 2024-07-03).
No takes yet. Share an insight, caveat, or question.
Mydłowska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: